Tamoxifen is a first-generation selective estrogen receptor modulator (SERM) medication used to treat estrogen receptor (ER)-positive breast cancer in men and women and as a prophylactic agent against breast cancer in women [2]. The gene discussed is ESR1; the disease is breast carcinoma.